Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 72162-1712

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 72162-1712). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A cumulative incidence curve comparing Atorvastatin to Placebo over a period of 3.5 years. The y-axis shows cumulative incidence percentage, while the x-axis represents time in years. The plot displays two lines: a solid line for Atorvastatin and a dashed line for Placebo, with Atorvastatin showing consistently lower incidence.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A line graph comparing cumulative hazard percentages over time for Atorvastatin versus placebo. The x-axis represents time to first primary endpoint over four years, and the y-axis shows cumulative hazard percentage. The Atorvastatin group has a lower hazard rate compared to placebo, as indicated by separate lines and accompanying hazard ratio statistics.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
A Kaplan-Meier curve showing the time to first major cardiovascular endpoint in years, comparing two Atorvastatin dosage groups: 10 mg (dashed line) and 80 mg (solid line). The y-axis represents the percentage of subjects experiencing the event, indicating fewer events in the 80 mg group over a 5-year period. Hazard ratio (HR) and statistical significance are noted on the graph.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of atorvastatin calcium showing its molecular arrangement, including calcium ions and characteristic aromatic rings typical of the active ingredient atorvastatin calcium.*
FDA Label Image

Label (Lbl721621712)

Label (Lbl721621712)
Label for Atorvastatin Calcium Tablets USP, 20 mg strength, in a package of 30 tablets. The label displays storage instructions, repackager Bryant Ranch Prepack, Inc. in Burbank, CA, and manufacturer Apotex Inc. It includes NDC 72162-1712-3, barcode, and a statement to dispense in a light-resistant container.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.